This article was originally published July 27.

Despite booking only one new PacBio RS system during the second quarter of 2012, Pacific Biosciences officials remain confident of the instrument's capabilities and said that increasing customer satisfaction, as well as focusing on base modification and hybrid assembly applications, will ultimately help drive adoption of the single-molecule sequencer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.